Adherence to non-invasive positive airway pressure therapy

Anne Kathrine Staehr-Rye; Tanja Ø Irlind; Simone H Küchen; Mona R Gätke

doi:10.1183/23120541.sleepandbreathing-2023.34

Abstract

Introduction: Studies have shown very different adherence to non-invasive positive airway pressure(nPAP) therapy. We aimed to investigate the adherence to nPAP therapy in patients with chronic respiratory insufficiency due to neuromuscular disorders(NMD), obesity-hypoventilation syndrome(OHS) or other reasons to sleep-disordered breathing(SDB) in the East of Denmark.

Methods: This cohort study included adult patients with association to the Respiratory Centre of the East of Denmark treated with nPAP therapy: bilevel(bipap), continuous(cpap) or adaptive servo-ventilation(ASV) with a remote monitoring system in April2022. Primary outcome was the number of adherent patients defined as median use of nPAP therapy >4hours/day.

Results: A total of 241 patients were included in the study.

The number of adherent patients with OHS was 56(64%), with NMD 97(75%) including dystrophia myotonica 3(27%) and with SDB,other 21(84%).

Conclusion: The proportion of patients that used nPAP therapy for more than 4 hrs per day was 73% in a danish population of adult patients with NMD, OHS and with other reasons to SDB. There were big differences in the proportions of adherent patients between the diagnoses.

Footnotes

Cite this article as ERJ Open Research 2023; 9: Suppl. 11, 34.

This article was presented at the 2023 Sleep and Breathing Conference, in session “Sleep implications of hypoventilation syndromes, central sleep apnoea and COVID-26”.

This is an Sleep and Breathing abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).